New pill offers hope for elderly ulcerative colitis patients
NCT ID NCT07243639
First seen Jan 10, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study is testing a new oral drug called etrasimod in 30 elderly patients with active ulcerative colitis. The goal is to see if the drug can control the disease by reducing inflammation and improving symptoms. Researchers will monitor patients for side effects and check their colon health over 52 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (DISORDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Showa Inan General Hospital
RECRUITINGKomagane, Nagano, 399-4117, Japan
Conditions
Explore the condition pages connected to this study.